Pharmaceuticals · Sales VP · Long Time No Contact
Cold Email Template for Pharmaceuticals Sales VP: Long Time No Contact
A cold email for a Pharmaceuticals Sales VP (long time no contact) is a short message that reopens the thread without making them do extra work. A cold email is a first-touch message to someone who didn't ask for it, so relevance has to show up before the pitch does. In this setting, that means speaking to follow-up that ignores
Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors
We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.
Sources: HubSpot sales email benchmarks; Gong follow-up research
Copy-ready template
Subject
Noticed [trigger] at [Company Name]
Body
Hi [First Name], If [pain] isn't a priority, you can delete this. I'm writing because a label update, a launch window, or a congress. Most [industry] teams I talk to aren't short on tools. They're short on [specific bottleneck]. That's the slice we handle. Given this is long time no contact, ask if the old problem still exists, or if you should leave it archived. Is [pain] even on the list, or am I early? Best, [Your Name] [Your Title] [Your Company]
Why this cold email works
- Show you understand their bottleneck in their language.
- Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
- Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
- Bring a new observation about their world, then offer a small, optional next step.
- Lead with an observed trigger, not a compliment about their About page.
When should I send this to a Pharmaceuticals Sales VP?
Don't follow a cold email the next morning. Give it 4 business days. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome.
What this Sales VP actually cares about
A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. 70 to 90 words. Lead with the outcome.
How Pharmaceuticals changes the note
Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Launch calendars and review boards set speed. You don't. Don't use consumer-startup slang. It's a credibility leak.
Customization tips
- Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
- Keep the tone crisp and commercial.
- Send from a real name. Role accounts get filtered.
- Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
- Don't use consumer-startup slang. It's a credibility leak.
Common mistakes
- Opening with your company story is how cold email dies.
- Don't open with 'it's been a while' and then paste the old pitch.
- Don't use consumer-startup slang. It's a credibility leak.
- Telling them how to sell. They've heard it.
How this scenario compares
| Dimension | For this template |
|---|---|
| Best send window | Only when you have a trigger |
| Ideal length | 70 to 90 words. Lead with the outcome. |
| Primary ask | a 15-minute look at one metric, not a platform tour |
| Industry metric to cite | time through MLR, access, and compliant engagement rates |
| Tone | Crisp and commercial. They can handle a direct ask. |
| Unlike no response | This isn't a 4-day bump. It's a re-introduction with a new reason. |
| Unlike breakup | You're opening a door, not closing one. Still keep it easy to ignore. |
Questions people ask before they hit send
Yes, when they're specific. Generic sequences got crushed by filters and fatigue. Short emails that cite a real trigger and ask a real question still get replies. Volume without relevance just trains spam systems. Tie the note to one metric or stall they already own, and keep the ask answerable in a single sentence.
Related templates
Cold Email for Pharmaceuticals Operations Manager (Long Time No Contact)
Cold Email for SaaS Sales VP (Long Time No Contact)
Meeting Request for Pharmaceuticals Sales VP (Long Time No Contact)
Cold Email for Pharmaceuticals Sales VP (No Response)
Cold Email for Pharmaceuticals Sales VP (Replied Then Silent)
Want a custom draft instead? Try the email generator.